BACKGROUND AND PURPOSE: The presence of active contrast extravasation (the spot sign) on computed tomography (CT) angiography has been recognized as a predictor of hematoma expansion in patients with intracerebral hemorrhage. We aim to systematically characterize the spot sign to identify features that are most predictive of hematoma expansion and construct a spot sign scoring system. METHODS: We retrospectively reviewed CT angiograms performed in all patients who presented to our emergency department over a 9-year period with primary intracerebral hemorrhage and had a follow-up noncontrast head CT within 48 hours of the baseline CT angiogram. Three neuroradiologists reviewed the CT angiograms and determined the presence and characteristics of spot signs according to strict radiological criteria. Baseline and follow-up intracerebral hemorrhage volumes were determined by computer-assisted volumetric analysis. RESULTS: We identified spot signs in 71 of 367 CT angiograms (19%), 6 of which were delayed spot signs (8%). The presence of any spot sign increased the risk of significant hematoma expansion (69%, OR=92, P<0.0001). Among the spot sign characteristics examined, the presence of > or =3 spot signs, a maximum axial dimension > or =5 mm, and maximum attenuation > or =180 Hounsfield units were independent predictors of significant hematoma expansion, and these were subsequently used to construct the spot sign score. In multivariate analysis, the spot sign score was the strongest predictor of significant hematoma expansion, independent of time from ictus to CT angiogram evaluation. CONCLUSIONS: The spot sign score predicts significant hematoma expansion in primary intracerebral hemorrhage. If validated in other data sets, it could be used to select patients for early hemostatic therapy.
BACKGROUND AND PURPOSE: The presence of active contrast extravasation (the spot sign) on computed tomography (CT) angiography has been recognized as a predictor of hematoma expansion in patients with intracerebral hemorrhage. We aim to systematically characterize the spot sign to identify features that are most predictive of hematoma expansion and construct a spot sign scoring system. METHODS: We retrospectively reviewed CT angiograms performed in all patients who presented to our emergency department over a 9-year period with primary intracerebral hemorrhage and had a follow-up noncontrast head CT within 48 hours of the baseline CT angiogram. Three neuroradiologists reviewed the CT angiograms and determined the presence and characteristics of spot signs according to strict radiological criteria. Baseline and follow-up intracerebral hemorrhage volumes were determined by computer-assisted volumetric analysis. RESULTS: We identified spot signs in 71 of 367 CT angiograms (19%), 6 of which were delayed spot signs (8%). The presence of any spot sign increased the risk of significant hematoma expansion (69%, OR=92, P<0.0001). Among the spot sign characteristics examined, the presence of > or =3 spot signs, a maximum axial dimension > or =5 mm, and maximum attenuation > or =180 Hounsfield units were independent predictors of significant hematoma expansion, and these were subsequently used to construct the spot sign score. In multivariate analysis, the spot sign score was the strongest predictor of significant hematoma expansion, independent of time from ictus to CT angiogram evaluation. CONCLUSIONS: The spot sign score predicts significant hematoma expansion in primary intracerebral hemorrhage. If validated in other data sets, it could be used to select patients for early hemostatic therapy.
Authors: S M Davis; J Broderick; M Hennerici; N C Brun; M N Diringer; S A Mayer; K Begtrup; T Steiner Journal: Neurology Date: 2006-04-25 Impact factor: 9.910
Authors: Stephan A Mayer; Nikolai C Brun; Kamilla Begtrup; Joseph Broderick; Stephen Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner Journal: N Engl J Med Date: 2005-02-24 Impact factor: 91.245
Authors: Stephan A Mayer; Nikolai C Brun; Joseph Broderick; Stephen Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: Ryan Wada; Richard I Aviv; Allan J Fox; Demetrios J Sahlas; David J Gladstone; George Tomlinson; Sean P Symons Journal: Stroke Date: 2007-02-22 Impact factor: 7.914
Authors: Steve Gazzola; Richard I Aviv; David J Gladstone; Gabriella Mallia; Vivian Li; Allan J Fox; Sean P Symons Journal: Stroke Date: 2008-02-21 Impact factor: 7.914
Authors: Javier M Romero; Jeremy J Heit; Josser E Delgado Almandoz; Joshua N Goldstein; Jingjing Lu; Elkan Halpern; Steven M Greenberg; Jonathan Rosand; R Gilberto Gonzalez Journal: Emerg Radiol Date: 2012-01-22
Authors: Javier M Romero; H Bart Brouwers; Jingjing Lu; Josser E Delgado Almandoz; Hillary Kelly; Jeremy Heit; Joshua Goldstein; Jonathan Rosand; R Gilberto Gonzalez Journal: Stroke Date: 2013-09-10 Impact factor: 7.914
Authors: Josser E Delgado Almandoz; Hillary R Kelly; Pamela W Schaefer; H Bart Brouwers; Albert J Yoo; Michael J Stone; Joshua N Goldstein; Jonathan Rosand; Michael H Lev; R Gilberto Gonzalez; Javier M Romero Journal: J Neurointerv Surg Date: 2011-10-15 Impact factor: 5.836
Authors: H Bart Brouwers; Alessandro Biffi; Alison M Ayres; Kristin Schwab; Lynelle Cortellini; Javier M Romero; Natalia S Rost; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: Stroke Date: 2012-04-24 Impact factor: 7.914
Authors: René van den Berg; Astrid L Rijssenbeek; Marieke E S Sprengers; Joost C J Bot; Charles B L M Majoie; Yvo B W E M Roos; William P Vandertop Journal: Interv Neuroradiol Date: 2014-02-10 Impact factor: 1.610
Authors: A Morotti; J M Romero; M J Jessel; H B Brouwers; R Gupta; K Schwab; A Vashkevich; A Ayres; C D Anderson; M E Gurol; A Viswanathan; S M Greenberg; J Rosand; J N Goldstein Journal: AJNR Am J Neuroradiol Date: 2016-05-19 Impact factor: 3.825